EpiBiologics
Series BEpiBiologics is a privately held company based in United States, founded in 2021. The latest disclosed round is Series B ($107m), dated Jan 08, 2026. Institutional investors on record include Google Ventures.
United States · EST 2021
What is EpiBiologics?
EpiBiologics is a privately held company based in United States, founded in 2021. The latest disclosed round is Series B ($107m), dated Jan 08, 2026. Institutional investors on record include Google Ventures. Developer of antibody-based targeted therapies to treat multiple diseases. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
Which funds backed EpiBiologics?
Who invested in EpiBiologics?
Funds on the dated round table. Open a name to read the fund card.
| Investor | Round | Amount | Date |
|---|---|---|---|
| Google Ventures | Series B | $107m | Jan 08, 2026 |
What do founders ask about EpiBiologics?
What is EpiBiologics?
EpiBiologics is a privately held company based in United States, founded in 2021. The latest disclosed round is Series B ($107m), dated Jan 08, 2026. Institutional investors on record include Google Ventures. Developer of antibody-based targeted therapies to treat multiple diseases. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
What was EpiBiologics's last funding round?
EpiBiologics's latest disclosed round is Series B at $107m (Jan 08, 2026).
Who invested in EpiBiologics?
EpiBiologics has 1 institutional investors on this page, including Google Ventures.
How does CrackTheDeck cover EpiBiologics?
This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.
How is this page compiled?
Round, amount, and investor names on the EpiBiologics card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.